Rhana Berto da Silva Prata

Rhana Berto da Silva Prata

Auto-generated profile, based on publicly available information

Rhana Berto da Silva Prata

Leprosy Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro 21040-360, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Microbes and Infection
Verified
Journal Article
Closed access
MBMayara Garcia de Mattos Barbosa
Mayara Garcia de Mattos Barbosa
RPRhana Berto da Silva Prata
Rhana Berto da Silva Prata
PAPriscila Ribeiro Andrade
Priscila Ribeiro Andrade
HFHelen Ferreira
Helen Ferreira
BSBruno de Andrade Silva
Bruno de Andrade Silva
Roberta Olmo PinheiroRoberta Olmo Pinheiro
Roberta Olmo Pinheiro

16 April 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
RPRhana Berto da Silva Prata
Rhana Berto da Silva Prata
Roberta Olmo PinheiroRoberta Olmo Pinheiro
Roberta Olmo Pinheiro
Infections caused by non-tuberculous mycobacteria (NTM), such as Mycobacterium abscessus, elicit diverse cell death mechanisms including apoptosis, necrosis, and pyroptosis, which play key roles in immunopathogenesis. NTM can manipulate these cell death pathways to evade host immune responses, ensuring their intracellular survival and persistence. Apoptosis may aid in antigen presentation and immune activation, while necrosis and pyroptosis trigger excessive inflammation, leading to tissue damage. Autophagy, a crucial cellular defense mechanism, is often induced in response to NTM infection; however, M. abscessus has evolved mechanisms to inhibit autophagic processes, enhancing its ability to survive within host cells. This manipulation of cell death pathways, particularly the dysregulation of autophagy and ferroptosis, contributes to chronic infection, immune evasion, and tissue damage, complicating disease management. Understanding these mechanisms offers potential therapeutic targets for improving treatment strategies against M. abscessus infections.

5 December 2024
Verified
Preprint
Open access
PDF file
RPRhana Prata
Rhana Prata
The work really shows the problems of the current situation with tuberculosis treatment drugs, demonstrating the need for the development of new molecules with high mycobactericidal potential. However, it is worth highlighting some points of the w...